TELEFLEX INC (TFX)

US8793691069 - Common Stock

211.11  +3.84 (+1.85%)

After market: 211.11 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

TELEFLEX INC

NYSE:TFX (4/23/2024, 7:04:00 PM)

After market: 211.11 0 (0%)

211.11

+3.84 (+1.85%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap9.94B
Shares
PE15.61
Fwd PE15.23
Dividend Yield0.66%
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

TFX Daily chart

Company Profile

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company is headquartered in Wayne, Pennsylvania and currently employs 15,500 full-time employees. The firm design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The firm has four segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM (Original Equipment Manufacturer and Development Services). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. OEM segment includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, which provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, sheath/dilator introducers, and more. The Company’s other brands include Arrow, LMA, Pilling, QuikClot, Rusch, UroLift, Weck, Barrigel, Deflux and Solesta.

Company Info

TELEFLEX INC

550 E Swedesford Rd, Suite 400

Wayne PENNSYLVANIA 19087

P: 16102256800

CEO: Liam J. Kelly

Employees: 15500

Website: https://www.teleflex.com/

TFX News

News Image6 days ago - Teleflex IncorporatedTeleflex Announces First Quarter 2024 Earnings Conference Call Information
News Image6 days ago - Teleflex IncorporatedTeleflex Announces First Quarter 2024 Earnings Conference Call Information

WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial...

News Image21 days ago - Market News VideoTrex Moves Up In Market Cap Rank, Passing Teleflex
News Image22 days ago - Teleflex IncorporatedTeleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
News Image22 days ago - Teleflex IncorporatedTeleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types

WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the...

News Imagea month ago - Teleflex IncorporatedTeleflex’s Climate Targets Validated by the Science Based Targets Initiative

Teleflex commits to reach net-zero greenhouse gas emissions across its value chain by 2050.

TFX Twits

Here you can normally see the latest stock twits on TFX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example